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Resting energy expenditure in patients with
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Andrew W. Gardner, PhD,a,b,c and Polly S. Montgomery, MS,a,b,c Oklahoma City, Okla
Objective: The primary aim of this study was to compare the resting energy expenditure of patients with intermittent
claudication and critical limb ischemia. A secondary aim was to identify predictors of resting energy expenditure.
Methods: One hundred patients limited by intermittent claudication and 40 patients with critical limb ischemia
participated in this study. Patients were assessed on resting energy expenditure, body composition, ankle brachial index
(ABI), and calf blood flow.
Results: Patients with critical limb ischemia had a lower resting energy expenditure than patients with intermittent
claudication (1429 190 kcal/day vs 1563 229 kcal/day; P .004), and higher body fat percentage (34.8 7.8% vs
31.5 7.8%; P .037), higher fat mass (30.0 9.3 kg vs 26.2 8.9 kg;P .016), and lower ABI (0.31 0.11 vs 0.79
0.23; P < .001). Resting energy expenditure was predicted by fat free mass (P < .0001), age (P < .0001), ABI (P <
.0001), ethnicity (P< .0001), calf blood flow (P .005), and diabetes (P .008). Resting energy expenditure remained
lower in the patients with critical limb ischemia after adjusting for clinical characteristics plus fat free mass (1473 27.8
kcal/day [mean SEM] vs 1527 19.3 kcal/day; P .031), but it was no longer different between groups after further
adjustment for ABI and calf blood flow (1494  25.2 kcal/day vs 1505  17.7 kcal/day; P  .269).
Conclusion: Resting energy expenditure is decreased with a progression in peripheral arterial disease (PAD) symptoms
from intermittent claudication to critical limb ischemia. Furthermore, patients with critical limb ischemia who are most
susceptible for decline in resting energy expenditure are older, African American patients with diabetes. The lower resting
energy expenditure of patients with critical limb ischemia, combined with their sedentary lifestyle, suggests that they are
at high risk for long-term positive energy balance and weight gain. (J Vasc Surg 2010;51:1436-41.)Peripheral arterial disease (PAD) is prevalent in 12% of
the United States population and is associated with in-
creased morbidity1-5 and mortality.6 Ambulatory dysfunc-
tion and lower physical activity level of patients with PAD
places them at greater risk for disuse atrophy of the lower
extremity musculature7 than is typically observed with nor-
mal aging.8 Fat free mass is the largest contributor to
resting energy expenditure in healthy controls,9 and in
patients with PAD and intermittent claudication.10
Patients with intermittent claudication have lower
whole-body resting energy expenditure than age-matched
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1436controls,10 even after adjustment for fat free mass. The
group difference in resting energy expenditure disappears
after further adjustment for ankle brachial index (ABI) and
calf blood flow, indicating that peripheral vascular measures
and fat free mass are predictive of resting energy expendi-
ture.10 Thus, patients with intermittent claudication are
more likely than controls to have an energy imbalance
favoring fat accumulation, increasing the risk for obesity,
abdominal obesity, and metabolic syndrome.11,12 Patients
with critical limb ischemia and rest pain may be even more
prone to an impaired resting energy expenditure than pa-
tients with intermittent claudication due to greater leg
ischemia, disuse muscle atrophy, and muscle denerva-
tion.13 However, little is known about whole-body resting
energy expenditure in patients with critical limb ischemia.
The primary purpose of this study was to compare the
resting energy expenditure of patients with intermittent
claudication and critical limb ischemia. We hypothesized
that the resting energy expenditure is lower in patients with
critical limb ischemia due to ischemia of the lower extrem-
ity musculature. A secondary aim was to identify predictors
of resting energy expenditure, in which we hypothesized
that fat free mass, ABI, and calf blood flow are the primary
predictors.
METHODS
Subjects
Recruitment. Patients participated in this study in the
Geriatrics, Research, Education, and Clinical Center at the
MarylandVeteransAffairsHealthCare System (MVAHCS) at
Baltimore. Patients were recruited from the Vascular Clinic at
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advertisements for a free evaluation of peripheral vascular
function and physical function. The procedures used in this
study were approved by the Institutional Review Boards at
the University of Maryland and the MVAHCS at Balti-
more. Written informed consent was obtained from each
patient before investigation.
Screening. Patients were included in this study if they
had Fontaine stage II or stage III PAD14 defined by the
following inclusion criteria: (1) a history of intermittent
claudication and an ABI 0.90 for patients with intermit-
tent claudication,15 (2) a history of rest pain and an ABI
0.40 for patients with critical limb ischemia,15 and (3)
nonsmoking status defined as not having smoked over the
preceding year, and confirmed by having the patients
breathe into a 2000 Series Ecolyzer carbon monoxide
analyzer (National Draeger, Inc, Pittsburgh, Pa) to assess
the concentration of carbon monoxide in the expired air.
Patients were excluded from this study for the following
conditions: (1) absence of PAD (ABI0.90),15 (2) inabil-
ity to obtain an ABI measure due to noncompressible
vessels, (3) asymptomatic PAD (Fontaine stage I PAD), (4)
severe PAD with tissue loss (Fontaine stage IV) or active
infection in the lower extremity, (5) current smoking, (6)
use of medications indicated for the treatment of intermit-
tent claudication (cilostazol and pentoxifylline), and (7)
active cancer, renal disease, or liver disease. A total of
140 patients were deemed eligible for this investigation,
whereas 38 patients were ineligible.
Measurements
Medical history and physical examination. Demo-
graphic information, height, weight, body mass index
(BMI), waist and hip circumferences,16 cardiovascular risk
factors, comorbid conditions, claudication history, and a
list of current medications were obtained during a physical
examination and medical history interview.
Resting energy expenditure. On a subsequent visit,
subjects arrived at the laboratory and were tested between
0700 and 0900 hours after a 12-hour overnight fast. A
Plexiglas ventilated hood was placed over the patient’s
heads as they rested supine in a darkened, quiet room
maintained at 24oC. Oxygen consumption and carbon
dioxide production were determined over 45 minutes of
supine rest with a computerized open-circuit indirect calo-
rimeter (Deltatrac SensormedicsMetabolic Monitor model
125, Anaheim, Calif).17 The first 15 minutes of the test
habituated patients to the instrumentation and testing
procedures. During the final 30 minutes of the test, oxy-
gen consumption and carbon dioxide production values
were obtained and used to calculate resting energy
expenditure.18
Body composition. Percentage of body fat was deter-
mined after a 12-hour overnight fast by a total body scan
with dual energy x-ray absorptiometry (model DPX-L,
LUNAR Radiation, Madison, Wis) in the supine position.7
All scans were analyzed using the LUNAR version 1.3
DPX-L extended analysis program for body composition.7ABI. After 10 minutes of supine rest, ankle and bra-
chial systolic pressures were obtained as previously de-
scribed.2,19 Measurements were taken from the posterior
tibial and dorsalis pedis arteries in both legs. The higher
arterial pressure from the more severely diseased leg was
recorded as the ankle systolic pressure. Brachial arterial
pressure was recorded from the arm yielding the higher
systolic pressure. From these measures, ABI was calculated
as ankle systolic pressure/brachial systolic pressure.19 The
test-retest intraclass reliability coefficient is r  0.96 for
ABI.2
Calf blood flow. Following the measurement of ABI,
calf blood flow in the more severely diseased leg was ob-
tained by venous occlusion strain-gauge plethysmography.
A mercury strain gauge was placed around the calf at the
maximal circumference, and arterial blood flow to the foot
was temporarily occluded by an ankle cuff inflated to 300
mmHg. Calf blood flow was measured by inflating a thigh
cuff to a venous occlusion pressure of 50mmHg. The ankle
and thigh cuffs were deflated immediately after the calf
blood flow measurement was obtained, and this measure-
ment was repeated five times. The average of the five trials
was calculated and used for calf blood flow.20 The test-
retest intraclass reliability coefficient is r  0.86 for calf
blood flow.20
Statistical analyses
Unpaired t tests were used to compare differences
between the patients with intermittent claudication and
critical limb ischemia for parametric measures, and Mann-
Whitney U tests were used to compare the groups for
nonparametric measures. Stepwise multiple regression was
performed to identify predictors of resting energy expendi-
ture. The clinical, body composition, and peripheral hemo-
dynamic measures that were considered in the modeling
were age, gender, ethnicity, diabetes, hypertension, dyslip-
idemia, abdominal obesity, obesity, body mass, fat mass, fat
free mass, body fat percentage, BMI, waist/hip ratio, ankle
systolic blood pressure, ABI, and calf blood flow. All anal-
yses were performed using the SPSS-PC statistical package
(SPSS Inc, Chicago, Ill). Statistical significance was set at
P  .05. Measurements are presented as means  SD.
RESULTS
The clinical characteristics, peripheral hemodynamic
measures, and body composition of the patients with inter-
mittent claudication and critical limb ischemia are shown in
Table I. Patients with critical limb ischemia were older (P
.039), had a lower proportion of whites (P  .018), and a
higher prevalence of diabetes (P  .041), hypertension
(P  .010), dyslipidemia (P  .023), abdominal obesity
(P  .018), and obesity (P  .033) than patients with
intermittent claudication. Furthermore, patients with crit-
ical limb ischemia had lower values for ankle systolic blood
pressure (P .001) and ABI (P .001), and higher values
for body mass (P  .033), fat mass (P  .016), body fat
percentage (P  .037), BMI (P  .040), and waist/hip
ratio (P .017). The resting energy expenditure measures
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ischemia are shown in Table II. Patients with critical limb
ischemia had lower values for resting energy expenditure
(P .024), resting oxygen uptake (P  .025), and a trend
for lower carbon dioxide production (P  .063) than
patients with intermittent claudication.
The multiple regression model predicting resting en-
ergy expenditure from clinical characteristics, body compo-
sition, and peripheral hemodynamic measures is shown in
Table III. Significant variables entering the model for rest-
Table I. Clinical characteristics, peripheral hemodynamic
measures, and body composition of patients with
peripheral arterial disease
Variables
Intermittent
claudication
group
(n  100)
Critical limb
ischemia group
(n  40) P value
Age (y) 68 (8) 71 (6) .039
Ankle systolic blood
pressure (mm Hg) 106 (32) 45 (19) .001
Ankle brachial index 0.79 (0.23) 0.31 (0.11) .001
Calf blood flow (%/min) 3.71 (1.33) 3.62 (1.30) .712
Resting heart rate
(beats/min) 62 (10) 64 (11) .206
Body mass (kg) 82.1 (13.2) 86.3 (12.7) .033
Fat mass (kg) 26.2 (8.9) 30.0 (9.3) .016
Fat free mass (kg) 55.9 (9.1) 56.3 (7.6) .498
Body fat (%) 31.5 (7.8) 34.8 (7.8) .037
Body mass index 27.7 (4.0) 29.9 (4.6) .040
Waist/hip ratio 0.93 (0.07) 0.97 (0.08) .017
Gender (% male) 85 85 1.000
Ethnicity (% white) 76 55 .018
Diabetes (% yes) 24 40 .041
Hypertension (% yes) 57 80 .010
Dyslipidemia (% yes) 47 65 .023
Abdominal obesity
(% yes) 44 65 .018
Obesity (% yes) 33 48 .033
Values are means (SD) or percentages.
Abdominal obesity was defined as having a waist girth 88 cm in women,
and102 cm in men. Obesity was defined as having a body mass index30
kg/m2.
Table II. Resting energy expenditure measures of
patients with peripheral arterial disease
Variables
Intermittent
claudication
group
(n  100)
Critical limb
ischemia group
(n  40)
P
value
Resting energy
expenditure (kcal/d) 1563 (229) 1429 (190) .004
Resting oxygen uptake
(mL/min) 228.7 (41.2) 209.0 (41.8) .005
Resting carbon dioxide
production (mL/min) 187.5 (30.8) 173.3 (32.6) .063
Respiratory exchange ratio 0.82 (0.05) 0.83 (0.05) .396
Values are means (SD).ing energy expenditure included fat free mass (P .0001),age (P  .0001), ABI (P  .0001), ethnicity (P  .0001),
calf blood flow (P .0050), and diabetes (P .0081). The
model coefficients shown in Table III indicate that resting
energy expenditure was positively associated with fat free
mass, ABI, and calf blood flow, and was negatively associ-
ated with age, ethnicity (lower values for African Americans
compared with whites), and diabetes.
The adjusted resting energy expenditure of patients
with intermittent claudication and critical limb ischemia is
displayed in Table IV. Resting energy expenditure re-
mained lower in the patients with critical limb ischemia
after adjusting for clinical characteristics (model 1; P 
.016), and clinical characteristics plus fat free mass (model
2; P  .031). Resting energy expenditure was no longer
different between the patients with intermittent claudica-
tion and critical limb ischemia after further adjustment for
ABI and calf blood flow (model 3; P  .269).
DISCUSSION
The main findings of this investigation were that: (1)
resting energy expenditure was lower in patients with crit-
ical limb ischemia than in patients with intermittent clau-
dication, (2) fat free mass was the strongest predictor of
resting energy expenditure, and (3) age, ABI, ethnicity, calf
blood flow, and diabetes were additional predictors of
resting energy expenditure after adjusting for fat free mass.
Differences in resting energy expenditure and fat
free mass. To our knowledge, this is the first investigation
to examine the whole-body resting energy expenditure in
patients with critical limb ischemia. Resting energy expen-
diture was 134 kcal/day lower in patients with critical limb
ischemia than in patients with intermittent claudication,
increasing their risk of being in positive energy balance. The
long-term metabolic impact of expending 134 fewer calo-
ries per day is substantial, as this equates to over 6 kilograms
of weight gain per year, thereby increasing the risk for
obesity, abdominal obesity, and metabolic syndrome. Even
after adjusting for clinical characteristics and fat free mass,
patients with critical ischemia still had a lower resting
energy expenditure, possibly due to lower oxygen uptake of
the lower extremities,21 and greater muscular ischemia.
Since patients with critical limb ischemia engage in less daily
physical activity22 than patients with intermittent claudica-
tion,4 the estimated weight gain solely from lower resting
energy expenditure is an underestimate of the potential
total weight gain. However, our data on body weight is in
contrast to a previous report showing a nonsignificant trend
for lower BMI in patients with critical limb ischemia than in
controls.23 This discrepancy may be due to our selection of
only nonsmoking patients because of the metabolic effects
of smoking, whichmay be an important factor for the lower
body weight found in PAD patients who smoke.20 Another
possibility for the discrepant findings is that our patients
with critical limb ischemia may have had a chronically
higher caloric intake than patients in the previous report.
Other predictors of resting energy expenditure. Fat
free mass was the strongest predictor of resting energy
expenditure, thus supporting previous work.9 However, fat
reedo
and
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 6 Gardner and Montgomery 1439free mass was not the only predictor of resting energy
expenditure, as other factors included in the model were
age, ABI, ethnicity, calf blood flow, and diabetes. The fact
that fat free mass did not entirely explain differences in
resting energy expenditure is supported by others,24,25 and
several possible reasons exist. One possibility is that the
muscle mass of the lower extremities is less metabolically
active with more severe PAD. This is supported by previous
work demonstrating a 50% reduction in oxygen uptake of
the calf musculature, measured by near infrared spectros-
copy, in patients with PAD than in controls.21 Previous
reports also have found that PAD is associated with im-
paired muscle oxygen utilization during the onset of exer-
cise,26,27 and a higher percentage of angular fibers, indica-
tive of muscle denervation.13,28 Additionally, patients with
PAD have a lower percentage of slow-twitch muscle fibers,
lower capillary-to-fiber ratio, and lower number of capillar-
ies in contact with each individual muscle fiber than age-
matched controls.29 All of these factors could be amplified
with progression of PAD, and thus contribute to lower
resting energy expenditure per kilogram of fat free mass in
patients with critical limb ischemia due to their greater
PAD severity.
Once fat free mass entered the regression model, the
associations between the remaining variables and resting
energy expenditure were assessed with the differences in fat
free mass being controlled. Other predictors of resting
energy expenditure included clinical characteristics such as
age, ethnicity, and diabetes, and peripheral hemodynamic
measures such as ABI and calf blood flow. Our findings in
Table III. Multiple regression model predicting resting en
hemodynamic measures, and body composition measures i
Independent variable* Model coefficient (S
Fat free mass 22.934 (1.577
Age 11.471 (1.932
ABI 5.123 (1.901
Ethnicity 101.212 (27.20
Calf blood flow 29.756 (10.40
Diabetes 65.2925 (16.31
ABI, Ankle brachial index; CI, confidence interval.
*Overall model results: F-test statistic  74.29 with 6 and 133 degrees of f
Table IV. Adjusted resting energy expenditure of patients
Variables
In
Model 1: adjusted resting energy expenditure (kcal/d)
Model 2: adjusted resting energy expenditure (kcal/d)
Model 3: adjusted resting energy expenditure (kcal/d)
Values are means (SEM).
Model 1: resting energy expenditure is adjusted for age, body mass index, w
obesity, and obesity.
Model 2: resting energy expenditure is adjusted for the variables in model 1
Model 3: resting energy expenditure is adjusted for the variables in model 1patients with PAD support previous studies reporting re-duced resting energy expenditure with age30 and in African
Americans compared with whites,31 and impaired skeletal
muscle oxygen uptake kinetics due to microvascular dys-
function in patients with PAD and diabetes.32 This is
supported by a recent observation that African American
patients with PAD have impaired small artery elasticity
compared with their white counterparts, indicating worse
microvascular function.33 Our finding that diabetes re-
duces resting energy expenditure in PAD patients is in
contrast to observations of higher values in patients with
diabetes without PAD,31,34 suggesting that impairment in
oxygen delivery to skeletal muscle in patients with PAD has
a greater net influence on reducing resting energy expen-
diture than hyperglycemia has on increasing resting energy
expenditure.34
ABI and calf blood flow were additional predictors of
resting energy expenditure, even after adjustment of fat free
mass and clinical characteristics, suggesting that both the
macrocirculation and the nutritive circulation impact rest-
ing energy expenditure in patients with PAD. This finding
supports previous work that resting energy expenditure is
not entirely explained by fat free mass and body composi-
tion.24,25 Thus, the greater hemodynamic impairment in
patients with critical limb ischemia, as measured by ABI, is
an additional factor related to resting energy expenditure.
Although the two groups had similar calf blood flow at rest,
our data suggest that small differences in calf blood flow,
reflecting nutritive circulation, explain additional variance
in resting energy expenditure. After ABI and calf blood
flow are included in the model, the resting energy expen-
expenditure from clinical characteristics, peripheral
tients with peripheral arterial disease
95% CI P value
19.798 to 26.071 .0001
15.315 to 7.628 .0001
1.322 to 8.924 .0001
155.335 to 47.089 .0001
9.052 to 50.459 .0050
97.923 to 32.663 .0081
m, P  .0001. Multiple r  0.907, r2  0.823.
peripheral arterial disease
ittent claudication
up (n  100)
Critical limb ischemia
group (n  40) P value
551 (20.8) 1445 (29.7) .016
527 (19.3) 1473 (27.8) .031
505 (17.7) 1494 (25.2) .269
ip ratio, gender, ethnicity, diabetes, hypertension, dyslipidemia, abdominal
fat free mass.
2 plus ankle/brachial index and calf blood flow.ergy
n pa
E)
)
)
)
7)
7)
5)with
term
gro
1
1
1
aist/h
plusditure was similar between the patients with critical limb
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no additional measurements were predictive of resting en-
ergy expenditure.
Clinical implications and study limitations. It is not
clear from this investigation whether lower resting energy
expenditure is a consequence of critical limb ischemia, or
vice versa. Regardless, further work is needed to examine
whether resting energy expenditure is modifiable through
interventions designed to increase peripheral hemody-
namic measures, fat free mass, and to improve the manage-
ment of diabetes, particularly in older African American
patients with critical limb ischemia. Possible interventions
may include a walking program to increase total daily
energy expenditure and the microcirculation of the lower
extremities, resistance training to increase fat free mass, and
more optimal medication therapy, particularly in patients
with diabetes. We have recently found that painful ambu-
lation is more metabolically costly than pain-free ambula-
tion in patients with intermittent claudication.35 Thus,
even a modest amount of ambulation done carefully at slow
cadence in patients with critical limb ischemia may be a
feasible approach to increase energy expenditure and coun-
teract their otherwise sedentary lifestyle22 without causing
undue injury to the lower extremities.
There are several limitations to this study. The cross-
sectional design comparing patients with intermittent clau-
dication and critical limb ischemia does not allow causality
to be established, as it is possible that patients with critical
limb ischemia had lower resting energy expenditure before
the development of their more advanced symptoms. Fur-
thermore, it is possible that other comorbid conditions not
evaluated in this study were related to their lower resting
energy expenditure. The present findings are also limited to
patients with PAD with intermittent claudication or critical
limb ischemia and rest pain who are current nonsmokers,
and may not be generalized to patients with less severe
(Fontaine stage I) and more severe (Fontaine stage IV)
PAD, or to patients who are current smokers. However,
these populations had the typical high prevalence of risk
factors for PAD, including diabetes, hypertension, dyslipi-
demia, and obesity. Thus, we believe the findings of this
study are representative of nonsmoking patients with inter-
mittent claudication and with critical limb ischemia and rest
pain.
In conclusion, resting energy expenditure is decreased
with a progression in PAD symptoms from intermittent
claudication to critical limb ischemia. Furthermore, pa-
tients with critical limb ischemia who are most susceptible
for decline in resting energy expenditure are older, African
American patients with diabetes. The lower resting energy
expenditure of patients with critical limb ischemia, com-
bined with their sedentary lifestyle,22 suggests that they are
at high risk for long-term positive energy balance and
weight gain.
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